Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/27/1991 | WO1991002716A3 Hydroxamic acid based collagenase inhibitors |
06/27/1991 | WO1991001963A3 Use of sebacic acid and derivatives thereof in enteral and parenteral nutrition and pharmaceutical compositions containing said compounds |
06/27/1991 | DE4040186A1 Use of 3-amino-propan-1,2-di:ol derivs. - as racemate, enantiomeric mixt. or pure enantiomer in treatment of diabetes mellitus |
06/27/1991 | DE3943541A1 Aluminium magnesium hydroxy fatty acid cpds. |
06/27/1991 | DE3942280A1 N-substituierte naphthalimide, ihre herstellung und verwendung N-substituted naphthalimides, their preparation and use |
06/27/1991 | CA2072360A1 Prodrug anhydride compositions |
06/27/1991 | CA2070660A1 Cell-cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product |
06/27/1991 | CA2046594A1 Octapeptide analogs of somatostatin having threonine at the sixth position |
06/27/1991 | CA2045601A1 Circumvention of human tumor drug resistance |
06/27/1991 | CA2032984A1 Thienobenzoxepin- and naphthothiophene-derivatives, a process and intermediates for their preparation and their use as medicaments |
06/27/1991 | CA2032925A1 Analgesic and anti-inflammatory medicine |
06/27/1991 | CA2031889A1 Antipicornaviral pyridazinamines |
06/26/1991 | WO1991009612A1 Tumor cell growth inhibitor |
06/26/1991 | EP0434628A1 Composition for cosmetics or pharmaceutical use |
06/26/1991 | EP0434625A2 IGF-I for treating adverse effect of steroid therapy |
06/26/1991 | EP0434621A2 Rifamycin derivatives and processes for the manufacture thereof |
06/26/1991 | EP0434571A2 New steroid derivatives with a substituted ethyl group on the position 10, process for their production, the use as a medicine of one of these compounds and pharmaceutical compositions containing it. |
06/26/1991 | EP0434570A2 Steroid products carrying a substituted thioethyl group in position 10, a process for their preparation and intermediates of this process, their use as medicines and pharmaceutical preparations containing them |
06/26/1991 | EP0434561A2 1-Naphthyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them |
06/26/1991 | EP0434560A1 New derivatives of substituted aminoacids, process for their preparation and pharmaceutical compositions containing them |
06/26/1991 | EP0434470A2 Protection against chemically-induced kidney damage by methimazole |
06/26/1991 | EP0434450A2 Therapeutic nucleosides |
06/26/1991 | EP0434445A2 Process to obtain new mixed copper aminoacidate complexes from phenanthrolines and their alkyl derivatives to be used as anticancerigenic agents |
06/26/1991 | EP0434444A1 Process to obtain new mixed copper aminoacidate complexes from phenylate Phenathrolines to be used as anticancerigenic agents |
06/26/1991 | EP0434405A1 Imidazo[4,5-c]pyridines as antiosteoporotic agents |
06/26/1991 | EP0434394A2 Compounds for treating inflammatory bowel disease |
06/26/1991 | EP0434385A2 Use of macrocyclic nitrogen containing compounds for the treatment of retroviral infections |
06/26/1991 | EP0434376A2 Ivermectin derivative compounds and process for preparing the same |
06/26/1991 | EP0434369A1 New benzodiazepine analogs |
06/26/1991 | EP0434365A2 HIV protease inhibitors useful for the treatment of aids |
06/26/1991 | EP0434364A2 Benzodiazepine analogs for treating panic syndrome and for directly inducing analgesia |
06/26/1991 | EP0434360A1 New benziodiazepine analogs |
06/26/1991 | EP0434341A1 Diazine derivatives |
06/26/1991 | EP0434249A2 Benzofuran derivatives |
06/26/1991 | EP0434202A1 Azabicyclo amides and esters as 5-HT3 receptor antagonists |
06/26/1991 | EP0434173A2 Use of NMDA receptor antagonists for treatment of chronic neurodegenerative diseases |
06/26/1991 | EP0434095A1 Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives |
06/26/1991 | EP0434094A1 Methods of using 2-isopropyl-2-phenylaminovaleronitriles immunosuppresants and vasodilators |
06/26/1991 | EP0434093A1 Omega-amino-alpha-phenylalkano-nitrile derivatives |
06/26/1991 | EP0434088A1 Pharmaceutical compositions containing L-carnitine |
06/26/1991 | EP0434057A2 Indolocarbazole derivatives, processes for their preparation and their use |
06/26/1991 | EP0434034A1 Oxazole derivatives |
06/26/1991 | EP0434021A2 4-Piperidine methanol derivatives for the treatment of glaucoma |
06/26/1991 | EP0434020A1 2,19-Methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors |
06/26/1991 | EP0433978A2 New process for the preparation of nojirimycin and related compounds |
06/26/1991 | EP0433928A1 2-Formylbenzylphosphonic acid derivatives, their preparation and their use for treatment of diseases caused by viruses |
06/26/1991 | EP0433909A2 Formulation |
06/26/1991 | EP0433898A2 Analogs of oxetanyl purines and pyrimidines |
06/26/1991 | EP0433897A2 Process for preparing an optically active cyclobutane nucleoside |
06/26/1991 | EP0433848A1 Crystalline magnesium valproate and a method for the preparation thereof |
06/26/1991 | EP0433842A2 1,2,3-Triazole derivatives active as inhibitors of the enzyme HMG-COA reductase and pharmaceutical compositions containing them |
06/26/1991 | EP0433817A1 Combined anti-inflammatory agent |
06/26/1991 | EP0433766A1 Compositions of antiallergics and antihistamines and methods for their use |
06/26/1991 | EP0433765A1 The use of immunomodulants as synergistic agents of chemotherapeutics in tumor therapy |
06/26/1991 | EP0433683A2 Use of benzothiazepines as potentiators of anti-cancer drugs |
06/26/1991 | EP0433682A2 Use of 2,4,5-tri(4-methoxyphenyl)-4,5-dihydroimidazole for the treatment of cancer |
06/26/1991 | EP0433679A2 Pharmaceutical compositions for inhibition of maillard's reaction |
06/26/1991 | EP0433678A1 Alkoxymethylidene epipodophyllotoxin glucosides |
06/26/1991 | EP0433662A2 Acat inhibitors |
06/26/1991 | EP0433648A1 Substituted pyrimidobenzimidazole derivatives |
06/26/1991 | EP0433624A1 Pharmaceutical compositions for the topical use containing pyridinol carbamate |
06/26/1991 | EP0433526A1 Medicine for the treatment of heart-circulatory illnesses, of arrhythmics in particular |
06/26/1991 | EP0433457A1 Antipruritic composition |
06/26/1991 | EP0433425A1 Process for penems |
06/26/1991 | EP0433390A1 Swine growth promotion |
06/26/1991 | EP0433360A1 Improvements relating to the production of prodrugs. |
06/26/1991 | EP0433304A1 Means and method for increasing skin respiration |
06/26/1991 | EP0433275A1 Composition based on heparin micropolysaccharides, active when administered orally. |
06/26/1991 | EP0190219B1 Composition for the treatment of haemorrhoids |
06/26/1991 | CN1052482A 氨基酸衍生物 Amino acid derivatives |
06/26/1991 | CN1052481A Lipid a analogs having immunoactivating and anti-tumor activity |
06/26/1991 | CN1052480A Thiazolidone derivatives, pharmaceutical compositions containing them and process for preparing same |
06/26/1991 | CN1052478A Lmproved process for preparing vinyl ethers |
06/26/1991 | CN1012959B Process for preparation of benzodiazepine |
06/26/1991 | CN1012958B Process for preparation of 2-hydroxy quinoline carboxylic acid derivatives |
06/26/1991 | CN1012957B Process for preparation of quinoline derivatives |
06/26/1991 | CA2044621A1 Inhibiting agent against the proliferation of tumour cells |
06/25/1991 | US5026883 Used for pharmaceutical, dietary or cosmetic purposes |
06/25/1991 | US5026882 Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase |
06/25/1991 | US5026873 Process for direct isolation of captopril |
06/25/1991 | US5026868 Indenyl imidazoles |
06/25/1991 | US5026861 Antiarthritic asthma agent, lipoxygenase inhibitors |
06/25/1991 | US5026858 Used for treating nausea, vomating, gastrointestinal disorders and centarl nervous system |
06/25/1991 | US5026857 Cetnral nervous system disorders; antiserotonine agent |
06/25/1991 | US5026856 Isoindoline derivative |
06/25/1991 | US5026855 Stereospecific process for the preparation of furo[3,4-c]pyridine, enantiomer, compounds thus obtained and therapeutical compositions thereof |
06/25/1991 | US5026853 Sleep and cardiovascular disorders |
06/25/1991 | US5026848 Novel generation of heteroaryloxyalkyl heterocycles with antipicornaviruses activities |
06/25/1991 | US5026843 Reacting the 7-amino derivative with 2-((2-(aminothiazol-4-yl) ,1-methoxyiminoacetylthio)benzothiazole in the presence of water, solvent and amine; amine salt formation followed by formation of the disodium hydrate |
06/25/1991 | US5026836 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides, pharmaceutical compositions, and processes of making |
06/25/1991 | US5026833 4G -alpha-D-glucopyranosyl rutin, and its preparation and uses |
06/25/1991 | US5026759 2-substituted-1-naphthols as 5-lipoxygenase inhibitors |
06/25/1991 | US5026733 Brain function-improving medicine |
06/25/1991 | US5026732 Use of avarone for the control of AIDS and ARC |
06/25/1991 | US5026731 Pharmaceutical composition and method of treating psychoses |
06/25/1991 | US5026728 Treatment of arthritis and inflammation using N,N-dimethylglycine |
06/25/1991 | US5026724 Compounds with bronchodilator activity |
06/25/1991 | US5026722 Indole derivatives |
06/25/1991 | US5026721 Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition |
06/25/1991 | US5026717 Glutamate inhibitors |